Please use this identifier to cite or link to this item: http://hdl.handle.net/10397/107554
PIRA download icon_1.1View/Download Full Text
DC FieldValueLanguage
dc.contributorDepartment of Health Technology and Informatics-
dc.creatorCheng, KH-
dc.creatorLi, W-
dc.creatorLee, FKH-
dc.creatorLi, T-
dc.creatorCai, J-
dc.date.accessioned2024-07-03T08:16:14Z-
dc.date.available2024-07-03T08:16:14Z-
dc.identifier.urihttp://hdl.handle.net/10397/107554-
dc.language.isoenen_US
dc.publisherMDPI AGen_US
dc.rightsCopyright: © 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).en_US
dc.rightsThe following publication Cheng K-H, Li W, Lee FK-H, Li T, Cai J. Pixelwise Gradient Model with GAN for Virtual Contrast Enhancement in MRI Imaging. Cancers. 2024; 16(5):999 is available at https://doi.org/10.3390/cancers16050999.en_US
dc.subjectMR-guided radiotherapyen_US
dc.subjectNasopharyngeal carcinomaen_US
dc.subjectTumor contrasten_US
dc.subjectVirtual contrast enhancementen_US
dc.titlePixelwise gradient model with GAN for virtual contrast enhancement in MRI imagingen_US
dc.typeJournal/Magazine Articleen_US
dc.identifier.volume16-
dc.identifier.issue5-
dc.identifier.doi10.3390/cancers16050999-
dcterms.abstractBackground: The development of advanced computational models for medical imaging is crucial for improving diagnostic accuracy in healthcare. This paper introduces a novel approach for virtual contrast enhancement (VCE) in magnetic resonance imaging (MRI), particularly focusing on nasopharyngeal cancer (NPC).-
dcterms.abstractMethods: The proposed model, Pixelwise Gradient Model with GAN for Virtual Contrast Enhancement (PGMGVCE), makes use of pixelwise gradient methods with Generative Adversarial Networks (GANs) to enhance T1-weighted (T1-w) and T2-weighted (T2-w) MRI images. This approach combines the benefits of both modalities to simulate the effects of gadolinium-based contrast agents, thereby reducing associated risks. Various modifications of PGMGVCE, including changing hyperparameters, using normalization methods (z-score, Sigmoid and Tanh) and training the model with T1-w or T2-w images only, were tested to optimize the model’s performance.-
dcterms.abstractResults: PGMGVCE demonstrated a similar accuracy to the existing model in terms of mean absolute error (MAE) (8.56 ± 0.45 for Li’s model; 8.72 ± 0.48 for PGMGVCE), mean square error (MSE) (12.43 ± 0.67 for Li’s model; 12.81 ± 0.73 for PGMGVCE) and structural similarity index (SSIM) (0.71 ± 0.08 for Li’s model; 0.73 ± 0.12 for PGMGVCE). However, it showed improvements in texture representation, as indicated by total mean square variation per mean intensity (TMSVPMI) (0.124 ± 0.022 for ground truth; 0.079 ± 0.024 for Li’s model; 0.120 ± 0.027 for PGMGVCE), total absolute variation per mean intensity (TAVPMI) (0.159 ± 0.031 for ground truth; 0.100 ± 0.032 for Li’s model; 0.153 ± 0.029 for PGMGVCE), Tenengrad function per mean intensity (TFPMI) (1.222 ± 0.241 for ground truth; 0.981 ± 0.213 for Li’s model; 1.194 ± 0.223 for PGMGVCE) and variance function per mean intensity (VFPMI) (0.0811 ± 0.005 for ground truth; 0.0667 ± 0.006 for Li’s model; 0.0761 ± 0.006 for PGMGVCE).-
dcterms.abstractConclusions: PGMGVCE presents an innovative and safe approach to VCE in MRI, demonstrating the power of deep learning in enhancing medical imaging. This model paves the way for more accurate and risk-free diagnostic tools in medical imaging.-
dcterms.accessRightsopen accessen_US
dcterms.bibliographicCitationCancers, Mar. 2024, v. 16, no. 5, 999-
dcterms.isPartOfCancers-
dcterms.issued2024-03-
dc.identifier.scopus2-s2.0-85187689456-
dc.identifier.eissn2072-6694-
dc.identifier.artn999-
dc.description.validate202407 bcch-
dc.description.oaVersion of Recorden_US
dc.identifier.FolderNumbera2930aen_US
dc.identifier.SubFormID48799en_US
dc.description.fundingSourceOthersen_US
dc.description.fundingTextShenzhen Basic Research Program (No. JCYJ20210324130209023) of Shenzhen Science and Technology Innovation Committee, Project of Strategic Importance Fund (No. P0035421) and Projects of RISA (No. P0043001) from The Hong Kong Polytechnic University of The Hong Kong Polytechnic University, Mainland-Hong Kong Joint Funding Scheme (MHKJFS) (No. MHP/005/20), and Health and Medical Research Fund (No. HMRF 09200576), the Health Bureau, The Government of the Hong Kong Special Administrative Region.en_US
dc.description.pubStatusPublisheden_US
dc.description.oaCategoryCCen_US
Appears in Collections:Journal/Magazine Article
Files in This Item:
File Description SizeFormat 
cancers-16-00999.pdf1.26 MBAdobe PDFView/Open
Open Access Information
Status open access
File Version Version of Record
Access
View full-text via PolyU eLinks SFX Query
Show simple item record

Page views

91
Citations as of Nov 10, 2025

Downloads

54
Citations as of Nov 10, 2025

SCOPUSTM   
Citations

4
Citations as of Dec 19, 2025

WEB OF SCIENCETM
Citations

3
Citations as of Dec 18, 2025

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.